New Jersey 1115 Medicaid Waiver Evaluations

CSHP Evaluation of the NJ FamilyCare Comprehensive Demonstration

Since 2012, Rutgers Center for State Health Policy (CSHP) has served as the independent evaluator for the NJ FamilyCare Comprehensive Demonstration, a Section 1115 Medicaid waiver demonstration initiative developed by the New Jersey Division of Medical Assistance and Health Services (DMAHS) and approved by the US Centers for Medicare and Medicaid Services (CMS) for three successive periods – 2012-2017, 2017-2022 (extended to March 2023), and 2023-2028.

This site provides links to CSHPs evaluation plans, journal articles, presentations, and reports related to the Demonstrations. Joel Cantor, the Center’s Director, serves as Principal Investigator for the Demonstration evaluation, with co-Investigators among the Center’s faculty and associates (currently including Ann Nguyen, John Palatucci, Hillary Samples, Amanda Spishak-Thomas, and Dan Treglia). Until 2023, the evaluation was led by Sujoy Chakravarty. Please contact Jennifer Farnham, Research Manager, with any questions about the evaluation.

2023-2028

Key Components of the Waiver 

• CMS-Approved Evaluation Plan

2017-2023

Key Components of the Waiver 

Articles and Presentations

• Lloyd, K., Chakravarty, S., Brownlee, S., Farnham, J. & Cantor, J.C. (2020). “Hospital Responses to DSRIP Program Reforms in New Jersey.” The American Journal of Accountable Care 8(2): 4-12.

Reports for CMS

Reports not yet approved by CMS or state; dates reflect initial submission to state reviewers:

• Analysis of the Children’s Health Insurance Program (CHIP) Continuous Coverage Provision to Examine Enrollment and Access to Care and Quality (August 2025) – Evaluation Plan
• Examining the Effect of the NJ FamilyCare Comprehensive Demonstration on Access to Care, Quality, and Cost of Care: Draft Summative Evaluation Report (August 2025, evaluation plan shown with interim report below)
• Draft Summative Evaluation of the NJ FamilyCare 1115 Substance Use Disorder Demonstration (March 2025, evaluation plan shown with interim report below)
• A Final Evaluation of the New Jersey Delivery System Reform Incentive Payment (DSRIP) Program: Assessing Program Impact on Outcomes and Cost-Effectiveness (December 2021)
• Stakeholder Feedback on Implementation of the Managed Care Expansion in Long-Term Services and Supports (Round 3, June 2020)

Reports approved by CMS or state:

• Interim Evaluation of the NJ FamilyCare 1115 Substance Use Disorder Demonstration (August 2022, includes eval plan)
• Examining the Effect of the NJ FamilyCare Comprehensive Demonstration on Access to Care, Quality, and Cost of Care: Interim Evaluation Report (August 2022, includes eval plan)
• The NJ FamilyCare Section 1115 Opioid and Substance Use Disorder Demonstration Program: Midpoint Assessment (January 2022)
• Evaluation of the New Jersey DSRIP Program: Findings from the Third Round of Stakeholder Interviews (September 2020)

2012-2017

Key Components of the Waiver 

Articles and Presentations

• Chakravarty, S., Lloyd, K., Farnham, J. & Brownlee, S. (2019). “Medicaid DSRIP in New Jersey: Tradeoffs between Broad Hospital Participation and Safety Net Viability.” Journal of Health Politics, Policy and Law 44(5): 789-806.
• Chakravarty S., and Lloyd K., "Evaluating the New Jersey Hospital DSRIP Program: Policy reforms in safety net delivery system transformation and financing", American Society of Health Economists Conference, Washington DC, 2019.
• Farnham, J., Chakravarty, S., Lloyd, K. Care Management for Long-Term Care Beneficiaries: New Jersey’s Move to Managed Care. Paper presented at “Consequences of Change in Healthcare for Organizations, Workers, and Patients,” a conference sponsored by the School of Management and Labor Relations at Rutgers University and the School of Industrial and Labor Relations at Cornell University, held at Rutgers January 9-11, 2019.
• Chakravarty S., DeLia D., Lloyd K., "Assessing the impact of state policies transitioning long term care services and supports from Fee-for-Service to managed care", American Society of Health Economists Conference, Atlanta, 2018.
• Chakravarty S, Lloyd K, Brownlee S, Farnham J., “A Midterm Assessment of the New Jersey DSRIP Program: Examining Implementation and Early Effects”, Poster Presentation, Academy Health Annual Research Meeting, Boston, 2016.
• Farnham, J., “Evaluation of Managed Long-Term Services and Supports (MLTSS).” Presentation to Good Care Collaborative, August 2015.

Reports for CMS

• A Summative Evaluation of the New Jersey DSRIP Program: Findings from Stakeholder Interviews, Hospital Surveys, Medicaid Claims Data, and Reported Quality Metrics (April 2018)
• Stakeholder Feedback on Implementation of the Managed Care Expansion in Long-Term Services and Supports (Second Round, June 2017)
• Examining the Effect of the NJ Comprehensive Waiver on Access to Care, Quality, and Cost of Care: Draft Final Evaluation Report (June 2017)
• Examining the Effect of the NJ Comprehensive Waiver on Access to Care, Quality, and Cost of Care: Draft Interim Evaluation Report (July 2016)
• A Midpoint Evaluation of the New Jersey DSRIP Program: Findings from Stakeholder Interviews, Hospital Survey, Medicaid Claims Data, and Reported Quality Metrics (September 2015)
• Initial Stakeholder Feedback on Implementation of the Managed Care Expansion in Long-Term Services and Supports (July 2015)

Federal and State Resources

• CMS-posted Demonstration-related Materials
• NJ Department of Human Services, Division of Medical Assistance & Health Services Demonstration-related Materials